Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03496662
Title BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

pancreatic ductal adenocarcinoma

Therapies

Nivolumab

BMS-813160 + Gemcitabine + Nab-paclitaxel

Gemcitabine + Nab-paclitaxel

BMS-813160 + Gemcitabine + Nab-paclitaxel + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.